Pattern and chemosensitivity of ovarian cancer in patients with BRCA1/2 mutations.
Our study adds to the BRCAness theory that hereditary ovarian cancers with BRCA 1 or 2 mutations show better chemosensitivity when compared with sporadic ovarian cancers.